APACMed Innovation Community

Of the estimated 30,000 medtech companies in the Asia Pacific, 90% or more are considered to be Small- and Medium-sized Enterprises (SMEs). Nearly USD 40 billion has been invested in medtech R&D in the region since the pandemic, a region which is looking at double-digit medtech industry growth and with said innovation serving as the lifeblood to achieving advancements in healthcare outcomes.

While many of these innovation concepts are backed by sound evidence, we face challenges of scale in the Asia Pacific. Enter the APACMed Innovation Community (AIC) – a medtech innovation ecosystem which brings together corporates, start-ups, investors, academia, incubators, advisors, and more. The APACMed SME portfolio consists of 200 companies and growing, spanning disease themes, geographies, and funding lifecycle status. Join AIC as we engage in capability development, matchmaking, policy advocacy, and more.